In an effort to protect GlaxoSmithKlines’ trade secrets, prosecutors in a corporate espionage case against two GSK scientists and three co-conspirators have asked the court to consider assigning a private security detail to handle the transportation of evidence.
The government’s request is the latest development in a debate among the parties about how the five defendants should be able to view discovery materials.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
